Clinical trial
Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable…
NCT00137852 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00137852 |
|---|---|
| Title | Cisplatin, CPT-11 and Celecoxib With Radiation Therapy and Surgery for Operable Esophageal Cancer |
| Official title | Phase II Trial of Cisplatin, CPT-11, Celecoxib (PCC), Concurrent Radiation Therapy, and Surgery for Resectable Esophageal Cancer |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | Brigham and Women's Hospital Massachusetts General Hospital Pharmacia Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Drug, Procedure |
| Interventions | Cisplatin, Irinotecan, Celecoxib, Radiation Therapy, Esophagectomy |
| Enrollment | 35 |
| Start date | Jan 1, 2002 |
| Primary completion | Aug 1, 2004 |
| Completion | Sep 1, 2017 |
| First posted | Aug 30, 2005 |
| Last update posted | Sep 20, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: